Research progress regarding the role of long non‑coding RNAs in osteosarcoma (Review)
- Authors:
- Yanli Zhang
- Yanchuan Pu
- Jin Wang
- Zicai Li
- Hulin Wang
-
Affiliations: Department of Orthopedics, Wuwei People's Hospital, Wuwei, Gansu 733000, P.R. China - Published online on: July 3, 2020 https://doi.org/10.3892/ol.2020.11807
- Pages: 2606-2612
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program. Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, Sun M and LaQuaglia M: Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol. 11:449–453. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, et al: Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 21:2011–2018. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Peng Z, Liu C and Wu M: New insights into long noncoding RNAs and their roles in glioma. Mol Cancer. 17:612018. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Z, Xiao L, Li J, Dong B and Wang C: Integrative analysis reveals driver long non-coding RNAs in osteosarcoma. Medicine (Baltimore). 98:e143022019. View Article : Google Scholar : PubMed/NCBI | |
|
Ren K, Ni Y, Li X, Wang C, Chang Q, Li Y, Gao Z, Wu S, Shi X, Song J, et al: Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma. J Cell Biochem. 120:12473–12488. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Egranov SD, Yang L and Lin C: Molecular mechanisms of long noncoding RNAs-mediated cancer metastasis. Genes Chromosomes Cancer. 58:200–207. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Akhade VS, Pal D and Kanduri C: Long noncoding RNA: Genome organization and mechanism of action. Adv Exp Med Biol. 1008:47–74. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Deans C and Maggert KA: What do you mean, ‘epigenetic’? Genetics. 199:887–896. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, Gao Y, Yao L, Liu Y, Huang L, Yan Z, Zhao W, Zhu P and Weng H: LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation. Oncogene. 37:3098–3112. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Deng J, Mueller M, Geng T, Shen Y, Liu Y, Hou P, Mamillapalli R, Taylor HS, Paidas M and Huang Y: Correction: H19 LncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses. Cell Death Dis. 10:5922019. View Article : Google Scholar : PubMed/NCBI | |
|
Jain AK, Xi Y, McCarthy R, Allton K, Akdemir KC, Patel LR, Aronow B, Lin C, Li W, Yang L and Barton MC: LncPRESS1 Is a p53-regulated LncRNA that safeguards pluripotency by disrupting SIRT6-mediated De-acetylation of histone H3K56. Mol Cell. 64:967–981. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tam C, Wong JH, Tsui SKW, Zuo T, Chan TF and Ng TB: LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: Updates in recent years. Appl Microbiol Biotechnol. 103:4649–4677. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Léveillé N and Baglio SR: Exosome-transferred LncRNAs at the core of cancer bone lesions. Crit Rev Oncol Hematol. 139:125–127. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dong Z and Wang Y: LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3. Pathol Res Pract. 215:571–579. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao W and Li L: SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma. Pathol Res Pract. 215:439–445. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen S, Li W and Guo A: LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma. Biosci Rep. 39:BSR201904472019. View Article : Google Scholar : PubMed/NCBI | |
|
Su X, Teng J, Jin G, Li J, Zhao Z, Cao X, Guo Y, Guo M, Li X, Wu J, et al: ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2. Biomed Pharmacother. 109:788–797. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang T, Wan CY, Mei XL, Jia P and Wang MJ: Long Non-coding RNA HULC promotes progression of bone neoplasms. Med Sci Monit. 24:5754–5760. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li P, Huang R, Huang T, Cheng S, Chen Y and Wang Z: Long non-coding RNA NEAT1 promotes proliferation, migration and invasion of human osteosarcoma cells. Int J Med Sci. 15:1227–1234. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Gu W, Zhang E, Song L, Tu L, Wang Z, Tian F, Aikenmu K, Chu G and Zhao J: Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2. Biomed Pharmacother. 106:890–895. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Ge D, Chen X, Qiu J, Yin Z, Zheng S and Jiang C: FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2. Biochem Biophys Res Commun. 502:493–500. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yu G, Liu G, Yuan D, Dai J, Cui Y and Tang X: Long non-coding RNA ANRIL is associated with a poor prognosis of osteosarcoma and promotes tumorigenesis via PI3K/Akt pathway. J Bone Oncol. 11:51–55. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ye H, Lin J, Yao X, Li Y, Lin X and Lu H: Overexpression of long Non-coding RNA NNT-AS1 correlates with tumor progression and poor prognosis in osteosarcoma. Cell Physiol Biochem. 45:1904–1914. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Zhang Y, Mao Y and Ma X: The LncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma. Onco Targets Ther. 11:629–638. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Tang Y, Xing W, Dong W and Wang Z: LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition. Exp Mol Pathol. 104:19–25. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bayoumi AS, Sayed A, Broskova Z, Teoh JP, Wilson J, Su H, Tang YL and Kim IM: Crosstalk between long noncoding RNAs and MicroRNAs in health and disease. Int J Mol Sci. 17:3562016. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang N, Wang X, Xie X, Liao Y, Liu N, Liu J, Miao N, Shen J and Peng T: LncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 405:46–55. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X, Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI | |
|
Ma H, Su R, Feng H, Guo Y and Su G: Long noncoding RNA UCA1 promotes osteosarcoma metastasis through CREB1-mediated epithelial-mesenchymal transition and activating PI3K/AKT/mTOR pathway. J Bone Oncol. 16:1002282019. View Article : Google Scholar : PubMed/NCBI | |
|
Liao S, Xing S and Ma Y: LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma. Cancer Chemother Pharmacol. 83:1065–1074. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang N, Meng X, Mei L, Zhao C and Chen W: LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway. J Cell Biochem. Mar 6–2019.doi: 10.1002/jcb.28426 (Epub Ahead of Print). | |
|
Sun Z, Zhang T and Chen B: Long Non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes proliferation and metastasis of osteosarcoma cells by targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b. Med Sci Monit. 25:1410–1422. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Deng R, Zhang J and Chen J: LncRNA SNHG1 negatively regulates miRNA-101-3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma. Int J Mol Med. 43:1157–1166. 2019.PubMed/NCBI | |
|
Wang J, Cao L, Wu J and Wang Q: Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88. 2018.PubMed/NCBI | |
|
Dai J, Xu L, Hu X, Han G, Jiang H, Sun H, Zhu G and Tang X: Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223. Biomed Pharmacother. 106:1441–1447. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Zhang T, Zhang Y, Zhao X and Wang W: Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma. Cancer Sci. 109:3093–3104. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li G, Liu K and Du X: Long Non-coding RNA TUG1 promotes proliferation and inhibits apoptosis of osteosarcoma cells by sponging miR-132-3p and Upregulating SOX4 expression. Yonsei Med J. 59:226–235. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Zhang R, Cheng G, Xu R and Han X: Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells. Cell Cycle. 17:1637–1648. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Deng Y, Zhao F, Zhang Z, Sun F and Wang M: Long noncoding RNA SNHG7 promotes the tumor growth and epithelial-to-mesenchymal transition via regulation of miR-34a Signals in osteosarcoma. Cancer Biother Radiopharm. 33:365–372. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Gu Z, Hou Z, Zheng L, Wang X, Wu L and Zhang C: Long noncoding RNA LINC00858 promotes osteosarcoma through regulating miR-139-CDK14 axis. Biochem Biophys Res Commun. 503:1134–1140. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li R, Liu S, Li Y, Tang Q, Xie Y and Zhai R: Long noncoding RNA AFAP1-AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR-4695-5p/TCF4-β-catenin signaling. Mol Med Rep. 18:1616–1622. 2018.PubMed/NCBI | |
|
Xia B, Wang L, Feng L, Tian B, Tan Y and Du B: Knockdown of long noncoding RNA CAT104 inhibits the proliferation, migration, and invasion of human osteosarcoma cells by regulating MicroRNA-381. Oncol Res. 27:89–98. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yang C, Wu K, Wang S and Wei G: Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p. J Cell Biochem. 119:5646–5656. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao J, Zhang C, Gao Z, Wu H, Gu R and Jiang R: Long non-coding RNA ASBEL promotes osteosarcoma cell proliferation, migration, and invasion by regulating microRNA-21. J Cell Biochem. 119:6461–6469. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou S, Yu L, Xiong M and Dai G: LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p. Biochem Biophys Res Commun. 495:1822–1832. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu KP, Ma XL and Zhang CL: LncRNA ODRUL contributes to osteosarcoma progression through the miR-3182/MMP2 Axis. Mol Ther. 25:2383–2393. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Luo P, Guo W, Shi Y, Xu D, Zheng H and Jia L: LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis. Biochem Biophys Res Commun. 503:1927–1933. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao D, Wang S, Chu X and Han D: LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression. Artif Cells Nanomed Biotechnol. 47:1342–1348. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao W, Zhang D, Qin P, Zhang J, Cui X, Gao J, Wang J and Li J: Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation. Int J Biol Macromol. 128:566–573. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen ZX, Li QC, Liu ZZ, Liang RD and Huang B: Long non-coding RNA RAB11B-AS1 prevents osteosarcoma proliferation via its sense gene RAB11B. Zhonghua Yi Xue Za Zhi. 98:2509–2514. 2018.(In Chinese). PubMed/NCBI | |
|
Qu G, Ma Z, Tong W and Yang J: LncRNA WWOX-AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells. Mol Med Rep. 18:779–788. 2018.PubMed/NCBI | |
|
Zhao J and Ma ST: Downregulation of LncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway. Mol Med Rep. 17:7388–7394. 2018.PubMed/NCBI | |
|
Zhang ZC, Tang C, Dong Y, Zhang J, Yuan T, Tao SC and Li XL: Targeting the long noncoding RNA MALAT1 blocks the pro-angiogenic effects of osteosarcoma and suppresses tumour growth. Int J Biol Sci. 13:1398–1408. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang SZ, Cai L and Li B: MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma. Bratisl Lek Listy. 118:632–636. 2017.PubMed/NCBI | |
|
Sun L, Yang C, Xu J, Feng Y, Wang L and Cui T: Long noncoding RNA EWSAT1 promotes osteosarcoma cell growth and metastasis through suppression of MEG3 expression. DNA Cell Biol. 35:812–818. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Guo W, Jiang H, Li H, Li F, Yu Q, Liu Y, Jiang W and Zhang M: LncRNA-SRA1 suppresses osteosarcoma cell proliferation while promoting cell apoptosis. Technol Cancer Res Treat. 18:15330338198414382019. View Article : Google Scholar : PubMed/NCBI | |
|
Fei D, Zhang X, Liu J, Tan L, Xing J, Zhao D and Zhang Y: Long noncoding RNA FER1L4 suppresses tumorigenesis by regulating the expression of PTEN targeting miR-18a-5p in osteosarcoma. Cell Physiol Biochem. 51:1364–1375. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Han W and Liu J: LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway. Biomed Pharmacother. 97:911–918. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yang C, Wang G, Yang J and Wang L: Long noncoding RNA NBAT1 negatively modulates growth and metastasis of osteosarcoma cells through suppression of miR-21. Am J Cancer Res. 7:2009–2019. 2017.PubMed/NCBI | |
|
Sun ZY, Jian YK, Zhu HY and Li B: LncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway. Pathol Res Pract. 215:555–563. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Qi X, Yu XJ, Wang XM, Song TN, Zhang J, Guo XZ, Li GJ and Shao M: Knockdown of KCNQ1OT1 suppresses cell invasion and sensitizes osteosarcoma cells to CDDP by upregulating DNMT1-mediated Kcnq1 expression. Mol Ther Nucleic Acids. 17:804–818. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Q, Hu T and Xu Y: Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling. J Drug Target. 28:204–211. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Song L, Zhou Z, Gan Y, Li P, Xu Y, Zhang Z, Luo F, Xu J, Zhou Q and Dai F: Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p. J Cell Biochem. 120:9656–9666. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li G and Zhu Y: Effect of LncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro. Pathol Res Pract. 215:931–938. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou B, Li L, Li Y, Sun H and Zeng C: Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis. Biomed Pharmacother. 106:850–857. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang CL, Zhu KP and Ma XL: Antisense LncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett. 396:66–75. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Han Z and Shi L: Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis. Biochem Biophys Res Commun. 495:947–953. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Zhao L and Wang Q: Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J Transl Res. 8:2385–2393. 2016.PubMed/NCBI | |
|
Hu T, Fei Z, Su H, Xie R and Chen L: Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling. Toxicol Appl Pharmacol. 371:55–62. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yarmishyn AA and Kurochkin IV: Long noncoding RNAs: A potential novel class of cancer biomarkers. Front Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI | |
|
Shi T, Gao G and Cao Y: Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics. Dis Markers. 2016:90851952016. View Article : Google Scholar : PubMed/NCBI | |
|
Begolli R, Sideris N and Giakountis A: LncRNAs as chromatin regulators in cancer: From molecular function to clinical potential. Cancers (Basel). 11:15242019. View Article : Google Scholar | |
|
Miranda-Castro R, de-Los-Santos-Álvarez N and Lobo-Castañón MJ: Long noncoding RNAs: From genomic junk to rising stars in the early detection of cancer. Anal Bioanal Chem. 411:4265–4275. 2019. View Article : Google Scholar : PubMed/NCBI |
